An experimental vaccine for covid-19 is showing some promising (though still very preliminary) results in people, according to its manufacturer. On Monday, biotech company Moderna announced its incomplete findings from a Phase 1 clinical trial of the vaccine candidate, called mRNA-1273. The trial found that the…
via Gizmodo